The Apollo Bramwell Hospital in conjunction with Global Biohealth Solutions has launched the Apollo Bramwell Stem Cell Therapy Program.

The Apollo Bramwell Hospital is the first hospital in the Apollo Hospitals Group to treat cardiovascular, vascular, orthopedic and sports injury conditions and diseases with bone marrow derived autologous (the patients own) stem cells. The Program is constantly evolving and aims to treat patients with neurological diseases in the future. The Program will also offer umbilical cord blood derived stem cell therapy as studies and trials in these fields progress.

The Apollo Bramwell physicians, in collaboration with leading university hospitals in Germany and France, use the latest FDA and EC registered point of care medical devices for the separation of autologous bone marrow concentrate rich in mononuclear cells.  These cells have proven in numerous clinical studies and trials to be a safe and effective method of achieving tissue regeneration. In the case of certain end-stage vascular diseases, angiogenesis and ultimately limb salvage have shown to be attainable. With certain cardiovascular diseases, improvements in ejection fraction and overall cardiac function have been recorded. In orthopedics, autologous bone marrow stem cell therapy has been shown to achieve bone healing in non-union bone fractures. Supporting documentation and published material is available to all physicians and patients on request.

For patients wishing to apply for stem cell therapy now, please fill in our Patient Application Form.